TDOCNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Teladoc Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$5.73+0.06 (+1.06%)
Close on Oct 19, 2026
- Market cap
- $1.04B
- P/E (TTM)
- –
- Dividend yield
- –
Teladoc Health statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Offices & Clinics of Doctors of Medicine companies for comparison
Valuation
| Measure | Teladoc Health | Industry median |
|---|---|---|
| Market Cap | $1.04B | $1.11B |
| Enterprise Value | $266.70M | $1.41B |
| PS Ratio | 0.42 | 1.60 |
| PB Ratio | 0.79 | 3.03 |
| P/FCF Ratio | 4.10 | 20.54 |
| P/OCF Ratio | 3.99 | 15.44 |
Enterprise value
| Measure | Teladoc Health | Industry median |
|---|---|---|
| EV / Sales | 0.11 | 1.69 |
| EV / FCF | 1.05 | 23.16 |
Income (trailing twelve months)
| Measure | Teladoc Health | Industry median |
|---|---|---|
| Revenue | $2.49B | $561.90M |
| Gross Profit | $1.72B | $173.32M |
| Operating Income | -$186.82M | -$1.81M |
| Pretax Income | -$182.59M | -$572.42K |
| Net Income | -$177.40M | -$1.16M |
| EBITDA | -$186.82M | -$20.72K |
| EPS (Diluted) | -$0.99 | -$0.02 |
Margins
| Measure | Teladoc Health | Industry median |
|---|---|---|
| Gross Margin | 69.0% | 33.1% |
| Operating Margin | -7.50% | -4.45% |
| Pretax Margin | -7.33% | 1.54% |
| Profit Margin | -7.13% | -2.91% |
| EBITDA Margin | -7.50% | 2.41% |
| FCF Margin | 10.2% | 3.13% |
Returns
| Measure | Teladoc Health | Industry median |
|---|---|---|
| Return on Equity (ROE) | -13.0% | 1.84% |
| Return on Assets (ROA) | -6.28% | -3.06% |
| Return on Invested Capital (ROIC) | -23.1% | 2.11% |
| Return on Capital Employed (ROCE) | -13.6% | -0.57% |
Growth
| Measure | Teladoc Health | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -2.08% | 6.92% |
| FCF Growth (YoY) | -13.0% | -6.04% |
| Revenue Growth (3Y CAGR) | 1.68% | 10.9% |
| Revenue Growth (5Y CAGR) | 18.3% | 13.2% |
Balance sheet
| Measure | Teladoc Health | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $774.35M | $48.71M |
| Net Cash (Debt) | $774.35M | $205.49K |
| Net Cash Per Share | $4.26 | $0.01 |
| Equity (Book Value) | $1.31B | $235.16M |
| Book Value Per Share | $7.21 | $3.48 |
| Tangible Book Value | -$148.75M | $703.69K |
| Working Capital | -$233.37M | $30.48M |
Financial position
| Measure | Teladoc Health | Industry median |
|---|---|---|
| Current Ratio | 0.83 | 1.40 |
| Quick Ratio | 0.72 | 1.02 |
| Interest Coverage | -9.36 | -0.63 |
Cash flow (trailing twelve months)
| Measure | Teladoc Health | Industry median |
|---|---|---|
| Operating Cash Flow | $261.18M | $3.10M |
| Capital Expenditures | -$7.49M | -$18.62M |
| Free Cash Flow | $253.70M | $23.73M |
| FCF Per Share | $1.40 | $0.37 |
Efficiency
| Measure | Teladoc Health | Industry median |
|---|---|---|
| Asset Turnover | 0.88 | 0.87 |
| Inventory Turnover | 23.07 | 11.67 |
| Revenue Per Employee | $444.55K | $228.48K |
| Profits Per Employee | -$31.68K | -$5.75K |
| Employee Count | 5,600 | 910 |
Dividends and yields
| Measure | Teladoc Health | Industry median |
|---|---|---|
| Earnings Yield | -17.0% | -0.59% |
| FCF Yield | 24.4% | 1.74% |
Shares
| Measure | Teladoc Health | Industry median |
|---|---|---|
| Shares Outstanding | 181,684,000 | 58,282,400 |
| Shares Change (YoY) | 2.96% | 2.68% |
| Shares Change (QoQ) | 0.68% | 0.32% |
| Float | 180,370,000 | 33,780,100 |
| Shares Held by Insiders | 0.72% | 16.4% |
| Shares Held by Institutions | 83.9% | 85.9% |
Taxes
| Measure | Teladoc Health | Industry median |
|---|---|---|
| Income Tax | -$5.20M | $697.00K |
Scores
| Measure | Teladoc Health | Industry median |
|---|---|---|
| Altman Z-Score | -7.38 | 2.05 |
| Piotroski F-Score | 6 | 5 |
Calculated by StockData from Teladoc Health's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.